Lehot Shares 5 Trends in MedTech Legal and Policy Issues
11 March 2021
MedTech Intelligence
Louis Lehot, partner with Foley & Lardner, recently authored an article for MedTech Intelligence, entitled, “Five Market, Investment, and M&A Trends in MedTech Meet Five Legal and Policy Issues.” Accelerated by the pandemic, medtech businesses have shown a tremendous potential for profitability and growth, which has triggered a sparked interest in investment. The article examines the medical technology industry and its outsized potential for profitability, resiliency, and growth, fueling an investment bonanza from private equity investors.
Full article can be found here.
People
Related News
31 March 2025
In the News
Louis Lehot Discusses the Current State of the IPO Market
Foley & Lardner LLP partner Louis Lehot was recently quoted in Barron's article, "The IPO Market and CoreWeave Sputter as Risk-Taking Wanes," where he discussed CoreWeave’s recent IPO and the current state of the IPO landscape.
28 March 2025
In the News
Louis Lehot Quoted in Law360 on CoreWeave IPO and 2025 IPO Outlook
Foley & Lardner LLP partner Louis Lehot was recently quoted in the Law360 article, "AI Startup CoreWeave's Tepid Debut Chills IPO Enthusiasm. "
27 March 2025
In the News
Vanessa Miller Weighs in on Trump Automotive Tariffs
Foley & Lardner LLP partner Vanessa Miller commented on the Trump administration's imposition of automotive tariffs in the Associated Press article, "Trump’s latest auto tariffs explained: What car buyers should know this year."